Skip to main content
. 2011 Sep 26;17(Suppl 6):E1–E59. doi: 10.1111/j.1469-0691.2011.03672.x
Reference Objective Design Evidence
Antonelli et al. [433] A multiple‐centre survey on the use in clinical practice of non‐invasive ventilation as a first‐line intervention for acute respiratory distress syndrome PCS 3A+
Bulow and Thorsager [434] Non‐invasive ventilation in do‐not‐intubate patients: 5‐year follow‐up on a 2‐year prospective, consecutive cohort study RCS 4B+
Confalonieri et al. [435] Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomized study RCT 2C−
Confalonieri et al. [431] Acute respiratory failure in patients with severe community‐acquired pneumonia. A prospective randomized evaluation of non‐invasive ventilation RCT 2B+
Ferrer et al. [432] Non‐invasive ventilation in severe hypoxaemic respiratory failure: a randomized clinical trial RCT 2B+
Gorman et al. [436] Corticosteroid treatment of severe community‐acquired pneumonia. MA 1A+
Mundy et al. [430] Early mobilization of patients hospitalized with community‐acquired pneumonia. Chest 2003; 124(3):883–889. Ref ID: 4438 PCS 3A+
Salluh et al. [437] The role of corticosteroids in severe community‐acquired pneumonia: a systematic review MA 1A+
Siempos et al. [438] Adjunctive therapies for community‐acquired pneumonia: a systematic review MA 1A+